FREE DELIVERY ON ALL US ORDERS OVER $50 →
WHYZ Learn
← Back to Creatine HCL

Creatine HCL Benefits: What the Research Shows

Updated March 30, 2026 by WHYZ Editorial Team

Quick Answer

Creatine HCL delivers the same active molecule as monohydrate, supporting strength, lean mass, and power output. Its primary practical advantage is dramatically improved water solubility, which may reduce GI issues and allows smaller serving sizes.

Creatine HCL is the hydrochloride salt of creatine, and the active compound it delivers is identical to every other creatine form. The benefits below are organized by evidence strength: outcomes demonstrated in HCL-specific trials are listed first, followed by benefits established in the broader creatine literature that apply by mechanism.

1. Increases Muscular Strength?

The most direct evidence for creatine HCL’s strength benefits comes from a 2024 randomized controlled trial by Eghbali et al. Forty young men (ages 18-25) were assigned to one of four groups: creatine HCL at 0.03 g/kg/day, creatine monohydrate with a 5-day loading phase, creatine monohydrate without loading, or placebo. All groups trained for 8 weeks at 70-85% of 1RM. The creatine HCL group showed statistically significant increases in 1RM strength compared to placebo, with results comparable to both monohydrate groups (Eghbali et al., 2024).

This finding is consistent with decades of creatine research. The meta-analysis by Rawson and Volek (2003) found that creatine supplementation increases maximal strength by an average of 14% and weightlifting performance by 8% when combined with resistance training, compared to training with placebo (Rawson & Volek, 2003). The mechanism is the same regardless of salt form: creatine expands the intramuscular phosphocreatine pool, enabling faster ATP regeneration during maximal efforts, which translates to more reps completed at a given weight and greater cumulative training volume over time.

2. Supports Lean Muscle Mass and Body Composition?

In the same Eghbali (2024) trial, the creatine HCL group gained significant skeletal muscle mass (SMM) and muscle cross-sectional area (MCSA) compared to placebo over the 8-week training period. Body fat percentage also decreased in all creatine groups relative to placebo. These changes did not differ between creatine HCL and either monohydrate protocol (Eghbali et al., 2024).

The ISSN 2017 position stand confirms that creatine supplementation combined with resistance training produces greater lean mass gains than training alone across diverse populations (Kreider et al., 2017). Creatine enables more total training volume per session, and the compounding effect of that additional volume over weeks drives measurably greater muscle protein synthesis signaling.

One body composition note specific to creatine HCL: because lower doses are typically used (1-2 g/day vs. 3-5 g/day for monohydrate, with no loading phase), the initial intracellular water retention that causes a rapid 1-2 kg weight gain in the first week of monohydrate loading may be less pronounced with HCL. For users who find early water weight psychologically discouraging, especially during a caloric deficit, this can be a practical advantage.

3. Improves Anabolic Hormone Profiles During Training?

The Eghbali (2024) RCT measured a panel of anabolic and catabolic hormones before and after the 8-week intervention. The creatine HCL group showed statistically significant increases in growth hormone (GH), insulin-like growth factor 1 (IGF-1), the testosterone-to-cortisol ratio, and the follistatin-to-myostatin ratio compared to placebo. Cortisol and adrenocorticotropic hormone (ACTH) both decreased (Eghbali et al., 2024).

These hormonal shifts favor an anabolic environment. Higher GH and IGF-1 support tissue repair and growth. A higher testosterone-to-cortisol ratio indicates reduced training-induced catabolic stress, and a favorable follistatin-to-myostatin ratio suggests reduced inhibition of muscle growth. The hormonal changes did not differ between creatine HCL and monohydrate, confirming that these effects stem from the creatine molecule itself, not from the hydrochloride salt form.

This is a single study with small group sizes (n=10 per group), so the hormonal data should be interpreted as preliminary rather than definitive.

4. Dissolves Completely in Water?

This is the most consistently cited practical advantage of creatine HCL over monohydrate. Creatine HCL dissolves at concentrations up to 38 times higher than monohydrate in water at room temperature. Where monohydrate often leaves gritty sediment at the bottom of a glass or shaker bottle, creatine HCL produces a fully clear solution with no residue.

Solubility may seem like a minor feature, but it has functional consequences:

Mixability. HCL dissolves in small volumes of water without clumping. No shaker bottle required. This matters for people who add creatine to coffee, juice, or other beverages where texture is noticeable.

GI comfort. Undissolved creatine powder reaching the lower intestine draws water into the gut lumen via osmosis, which can cause bloating, cramping, and loose stools. Some monohydrate users report these symptoms during loading phases (20 g/day). Because HCL dissolves completely before reaching the gut, this mechanism is largely eliminated. This benefit has not been formally tested in a head-to-head GI symptom trial, but it is consistent with the physical chemistry and with anecdotal reports from users who switched from monohydrate to HCL.

Smaller servings. At 1-2 g/day, the volume of powder is substantially less than a 5 g monohydrate scoop. This makes it easier to travel with and more discreet to use.

5. May Work Without a Loading Phase?

Traditional creatine monohydrate protocols often include a loading phase: 20 g/day (split into 4 doses) for 5-7 days, followed by 3-5 g/day maintenance. Loading is optional for monohydrate and simply accelerates the time to full muscle creatine saturation from 3-4 weeks to under one week.

Creatine HCL protocols typically skip loading entirely. In the Eghbali (2024) study, the HCL group used only a maintenance-level dose (0.03 g/kg/day) for the full 8 weeks and achieved strength and body composition outcomes comparable to the monohydrate group that did load (Eghbali et al., 2024). This suggests that creatine HCL at maintenance doses may reach effective intramuscular creatine levels without the GI discomfort and hassle of a loading week.

This is a single-study finding. Whether HCL actually saturates muscle creatine stores faster or simply reaches a sufficient threshold at lower doses has not been directly measured via muscle biopsy in humans. The practical takeaway: you can start HCL at your maintenance dose from day one and expect positive results over an 8-week training block.

6. May Support Cognitive Function?

A 2026 RCT by Korovljev et al. examined 8 weeks of creatine HCL supplementation on cognition and brain creatine levels in perimenopausal and menopausal women (Korovljev et al., 2026). This is one of the first studies to investigate creatine HCL specifically for brain-related outcomes and in a population (menopausal women) where declining estrogen may affect brain creatine metabolism.

The broader creatine-cognition evidence base supports this direction. Avgerinos et al. (2018) conducted a systematic review of RCTs and found that creatine supplementation improves short-term memory and reasoning in healthy adults, with effects most pronounced under conditions of stress or sleep deprivation (Avgerinos et al., 2018). The brain uses approximately 20% of the body’s total energy and maintains its own phosphocreatine stores. Supplemental creatine increases brain creatine content, particularly in populations with lower baseline levels such as vegetarians and older adults.

Cognitive benefits from creatine HCL are plausible based on mechanism, but the HCL-specific evidence is still in its early stages. This is a developing area of research.

What Does Creatine HCL NOT Do Better Than Monohydrate?

Transparency matters. Based on current evidence:

It is not more bioavailable. Solubility and bioavailability are different properties. Alraddadi et al. (2018) demonstrated that creatine monohydrate already has near-complete oral bioavailability in animal models (Alraddadi et al., 2018). No human study has shown that HCL produces greater muscle creatine saturation than monohydrate at equivalent doses.

It does not produce superior strength or hypertrophy outcomes. The Eghbali (2024) RCT found HCL comparable to monohydrate, not superior. No other head-to-head trial has demonstrated HCL outperforming monohydrate for any performance metric.

It costs more per gram. Creatine monohydrate is one of the most affordable supplements available. HCL typically costs 2-4x more per serving, though the smaller serving size partially offsets this difference.

References

  1. Eghbali E, Arazi H, Suzuki K. Supplementing with which form of creatine (hydrochloride or monohydrate) alongside resistance training can have more impacts on anabolic/catabolic hormones, strength and body composition? Physiol Res. 2024. 73(5):739-753. PMID: 39545789

  2. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017. 14:18. PMID: 28615996

  3. Rawson ES, Volek JS. Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. J Strength Cond Res. 2003. 17(4):822-831. PMID: 14636102

  4. Korovljev D, et al. The effects of 8-week creatine hydrochloride and creatine ethyl ester supplementation on cognition, clinical outcomes, and brain creatine levels in perimenopausal and menopausal women. J Am Nutr Assoc. 2026. PMID: 40854087

  5. Avgerinos KI, Spyrou N, Bougioukas KI, Kapogiannis D. Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Exp Gerontol. 2018. 108:166-173. PMID: 29704637

  6. Alraddadi EA, et al. Absolute oral bioavailability of creatine monohydrate in rats: debunking a myth. Pharmaceutics. 2018. 10(1):31. PMID: 29518030

Written by WHYZ Editorial Team · Last updated March 2026

Not medical advice. Editorial policy →